ClariTrial | Search Clinical Trials

Explore/atopic dermatitis

Status

Phase

Pre-filtered to show active, later-stage trials with the strongest clinical signal.

232 results for “atopic dermatitis” · Recruiting

Page 1 of 16

Recruiting

Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down Syndrome

Phase 2Atopic DermatitisAlopecia Areata

Abrocitinib

Icahn School of Medicine at Mount Sinai56 participants1 site · United StatesCompletes Feb 2029

Compare CT.gov Full analysis →

Recruiting

Topical Cannabidiol Lotion for Pruritus Relief in Scleroderma

Phase 3MediciineSystemic Sclerosis (SSc)Intervention Study

10% urea lotion plus 1% cannabidiolControl

Khon Kaen University36 participants1 site · ThailandCompletes Dec 2027

Compare CT.gov Full analysis →

Recruiting

Tissue Repository: CTCL Collection Protocol

N/ALymphoma, T-Cell, CutaneousLymphomatoid PapulosisSézary Syndrome

Columbia University400 participants1 site · United StatesCompletes Oct 2026

Compare CT.gov Full analysis →

Recruiting

Treatment and Medical Care of Patients With Moderate-to-severe Atopic Dermatitis - TREATswitzerland

N/AAtopic Dermatitis

Swiss Society of Dermatology and Venereology700 participants9 sites · SwitzerlandCompletes May 2032

Compare CT.gov Full analysis →

Recruiting

Phase III Clinical Study of VC005 in Adult and Adolescents With Mild to Moderate Atopic Dermatitis

Phase 3Atopic Dermatitis

VC005VC005 Placebo

Jiangsu vcare pharmaceutical technology co., LTD360 participants1 site · ChinaCompletes May 2028

Compare CT.gov Full analysis →

Recruiting

Pharmacokinetics, Safety and Efficacy of Nemolizumab in Participants Aged 6 to 23 Months With Moderate-to Severe Atopic Dermatitis

Phase 2Moderate-to-Severe Atopic Dermatitis

Nemolizumab

Galderma R&D35 participants1 site · United StatesCompletes Jul 2028

Compare CT.gov Full analysis →

Recruiting

Mechanisms of Increased Disease Severity in AD Patients With the IL-4Ra R576 Polymorphism

N/AAtopic Dermatitis

Boston Children's Hospital111 participants1 site · United StatesCompletes Mar 2027

Compare CT.gov Full analysis →

Recruiting

A Study to Evaluate Efficacy and Safety of IBI356 in Participants With Moderate to Severe Atopic Dermatitis

Phase 2Atopic Dermatitis

DupilumabPlaceboIBI356

Innovent Biologics (Suzhou) Co. Ltd.403 participants1 site · ChinaCompletes Jun 2027

Compare CT.gov Full analysis →

Recruiting

Efficacy and Safety of Methotrexate Versus Placebo in Adults With Atopic Dermatitis.

Phase 3Moderate to Severe Atopic Dermatitis

MethotrexatePlacebo

medac GmbH277 participants30 sites · Czechia, France, ItalyCompletes Nov 2026

Compare CT.gov Full analysis →

Recruiting

Evaluation of Stigma Toward Patients With Alopecia Areata, Atopic Dermatitis, Vitiligo, and Psoriasis

N/APsoriasis (PsO)Vitiligo VulgarisAtopic Dermatitis

Fondazione Policlinico Universitario Agostino Gemelli IRCCS400 participants1 site · ItalyCompletes Feb 2026

Compare CT.gov Full analysis →

Recruiting

FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients

Phase 1Healthy ParticipantsAtopic Dermatitis

PF-07832837Placebo

Pfizer119 participants5 sites · United StatesCompletes Jun 2027

Compare CT.gov Full analysis →

Recruiting

Evaluation of 611 in Chinese Adolescents With Moderate to Severe Atopic Dermatitis

Phase 3Dermatitis, Atopic

611Matching placebo

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.180 participants3 sites · ChinaCompletes Jun 2026

Compare CT.gov Full analysis →

Recruiting

Frequency of Palpebral Involvement in Adult With Atopic Dermatitis

N/AAtopic Dermatitis

Standard dermatology consultation

University Hospital, Lille550 participants2 sites · FranceCompletes Jun 2026

Compare CT.gov Full analysis →

Recruiting

A Prospective Cohort Study on Primary Cutaneous Amyloidosis

Phase 4Primary Cutaneous Amyloidosis

Tofacitinib and Acitretin Capsules.Acitretin Capsules.

Army Medical University, China56 participants1 site · ChinaCompletes Oct 2025

Compare CT.gov Full analysis →

Recruiting

Evaluation of the Prevalence of BP180 and BP230 Autoantibodies in the Serum of Patients With Pruritus Under Immunotherapy

N/APatients With Chronic Pruritus for More Than 1 Month Who Have Received Immunotherapy

characterisation of immunoglobulin subclasses

University Hospital, Rouen100 participants1 site · FranceCompletes Feb 2027

Compare CT.gov Full analysis →

1–15 of 232

Explore/atopic dermatitis

Status

Phase

Pre-filtered to show active, later-stage trials with the strongest clinical signal.

232 results for “atopic dermatitis” · Recruiting

Page 1 of 16

Recruiting

Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down Syndrome

Phase 2Atopic DermatitisAlopecia Areata

Abrocitinib

Icahn School of Medicine at Mount Sinai56 participants1 site · United StatesCompletes Feb 2029

Compare CT.gov Full analysis →

Recruiting

Topical Cannabidiol Lotion for Pruritus Relief in Scleroderma

Phase 3MediciineSystemic Sclerosis (SSc)Intervention Study

10% urea lotion plus 1% cannabidiolControl

Khon Kaen University36 participants1 site · ThailandCompletes Dec 2027

Compare CT.gov Full analysis →

Recruiting

Tissue Repository: CTCL Collection Protocol

N/ALymphoma, T-Cell, CutaneousLymphomatoid PapulosisSézary Syndrome

Columbia University400 participants1 site · United StatesCompletes Oct 2026

Compare CT.gov Full analysis →

Recruiting

Treatment and Medical Care of Patients With Moderate-to-severe Atopic Dermatitis - TREATswitzerland

N/AAtopic Dermatitis

Swiss Society of Dermatology and Venereology700 participants9 sites · SwitzerlandCompletes May 2032

Compare CT.gov Full analysis →

Recruiting

Phase III Clinical Study of VC005 in Adult and Adolescents With Mild to Moderate Atopic Dermatitis

Phase 3Atopic Dermatitis

VC005VC005 Placebo

Jiangsu vcare pharmaceutical technology co., LTD360 participants1 site · ChinaCompletes May 2028

Compare CT.gov Full analysis →

Recruiting

Pharmacokinetics, Safety and Efficacy of Nemolizumab in Participants Aged 6 to 23 Months With Moderate-to Severe Atopic Dermatitis

Phase 2Moderate-to-Severe Atopic Dermatitis

Nemolizumab

Galderma R&D35 participants1 site · United StatesCompletes Jul 2028

Compare CT.gov Full analysis →

Recruiting

Mechanisms of Increased Disease Severity in AD Patients With the IL-4Ra R576 Polymorphism

N/AAtopic Dermatitis

Boston Children's Hospital111 participants1 site · United StatesCompletes Mar 2027

Compare CT.gov Full analysis →

Recruiting

A Study to Evaluate Efficacy and Safety of IBI356 in Participants With Moderate to Severe Atopic Dermatitis

Phase 2Atopic Dermatitis

DupilumabPlaceboIBI356

Innovent Biologics (Suzhou) Co. Ltd.403 participants1 site · ChinaCompletes Jun 2027

Compare CT.gov Full analysis →

Recruiting

Efficacy and Safety of Methotrexate Versus Placebo in Adults With Atopic Dermatitis.

Phase 3Moderate to Severe Atopic Dermatitis

MethotrexatePlacebo

medac GmbH277 participants30 sites · Czechia, France, ItalyCompletes Nov 2026

Compare CT.gov Full analysis →

Recruiting

Evaluation of Stigma Toward Patients With Alopecia Areata, Atopic Dermatitis, Vitiligo, and Psoriasis

N/APsoriasis (PsO)Vitiligo VulgarisAtopic Dermatitis

Fondazione Policlinico Universitario Agostino Gemelli IRCCS400 participants1 site · ItalyCompletes Feb 2026

Compare CT.gov Full analysis →

Recruiting

FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients

Phase 1Healthy ParticipantsAtopic Dermatitis

PF-07832837Placebo

Pfizer119 participants5 sites · United StatesCompletes Jun 2027

Compare CT.gov Full analysis →

Recruiting

Evaluation of 611 in Chinese Adolescents With Moderate to Severe Atopic Dermatitis

Phase 3Dermatitis, Atopic

611Matching placebo

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.180 participants3 sites · ChinaCompletes Jun 2026

Compare CT.gov Full analysis →

Recruiting

Frequency of Palpebral Involvement in Adult With Atopic Dermatitis

N/AAtopic Dermatitis

Standard dermatology consultation

University Hospital, Lille550 participants2 sites · FranceCompletes Jun 2026

Compare CT.gov Full analysis →

Recruiting

A Prospective Cohort Study on Primary Cutaneous Amyloidosis

Phase 4Primary Cutaneous Amyloidosis

Tofacitinib and Acitretin Capsules.Acitretin Capsules.

Army Medical University, China56 participants1 site · ChinaCompletes Oct 2025

Compare CT.gov Full analysis →

Recruiting

Evaluation of the Prevalence of BP180 and BP230 Autoantibodies in the Serum of Patients With Pruritus Under Immunotherapy

N/APatients With Chronic Pruritus for More Than 1 Month Who Have Received Immunotherapy

characterisation of immunoglobulin subclasses

University Hospital, Rouen100 participants1 site · FranceCompletes Feb 2027

Compare CT.gov Full analysis →

1–15 of 232